Publications

Journal of Clinical Oncology · 2025

Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma

Molecular assessment of remission in large B-cell lymphoma.

Roschewski et al.

Nature · 2024

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

Noninvasive genomic profiling and the molecular diversity of Hodgkin lymphoma.

Alig*, Esfahani*, Garofalo*, Li* et al.

Cancer Cell · 2023

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

Investigating resistance to CD19-targeted cellular therapies.

Sworder*, Kurtz*, Alig*, Frank* et al.

Journal of Clinical Oncology · 2023

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas

Mutter*, Alig* et al.

Blood Advances · 2023

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Cherng*, Alig* et al.

Nature Biotechnology · 2022

Inferring gene expression from cell-free DNA fragmentation profiles

Esfahani et al.

Journal of Clinical Oncology · 2021

Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma

Alig*, Macaulay*, Kurtz* et al.

Nature Biotechnology · 2021

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

Kurtz et al.